Latest filing published 02 Feb 2011 for KING PHARMACEUTICALS INC.
No signal scores available.
All filings by Frederick Brouillette Jr. on record concern King Pharmaceuticals Inc. In total, 28 filings cover trades dated from 20 March 2006 to 31 January 2011.
Every open-market trade on record is a sale: 5 sales worth €266k. Besides market trades, the filings include 16 share grants and 5 option exercises.
The newest entry dates from 2 February 2011: a transaction, in King Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations